- All Courts
- Federal Courts
- Bankruptcies
- PTAB
- ITC
Filters
Like full text docket searches?
Get docket alerts, perform legal research, get updates of major decisions and orders, use our advanced analytics, and more. Request a Demo or create your account.
Date Filed
Dollars
Find cases based on dollar amount with searches like:
$100k-$10M.
Read the details here.
Displaying 699-713 of
1,230 results
3002 Exhibit: Exhibit 3002
Document
IPR2021-00816, No. 3002-681 Exhibit - Exhibit 3002 (P.T.A.B. May. 25, 2022)
|
|
Cite Document
2059 Exhibit: 2059
Document
IPR2021-00816, No. 2059-154 Exhibit - 2059 (P.T.A.B. Jul. 28, 2021)
|
|
Cite Document
2254 Exhibit: Ex 2254 NOVITCCH00885630 Public Redacted Version
Document
IPR2021-00816, No. 2254-482 Exhibit - Ex 2254 NOVITCCH00885630 Public Redacted Version (P.T.A.B. Jan. 19, 2022)
|
|
Cite Document
2270 Exhibit: Ex 2270 FDA Approves Eylea PFS Article
Document
IPR2021-00816, No. 2270-408 Exhibit - Ex 2270 FDA Approves Eylea PFS Article (P.T.A.B. Jan. 19, 2022)
|
|
Cite Document
2119 Exhibit: Ex 2119 NOVITCCH00003455 PUBLIC REDACTED VERSION
Document
IPR2021-00816, No. 2119-421 Exhibit - Ex 2119 NOVITCCH00003455 PUBLIC REDACTED VERSION (P.T.A.B. Jan. 19, 2022)
|
|
Cite Document
2259 Exhibit: Ex 2259 Avastin Prescribing Information Part 1 of 4
Document
IPR2021-00816, No. 2259-395 Exhibit - Ex 2259 Avastin Prescribing Information Part 1 of 4 (P.T.A.B. Jan. 19, 2022)
|
|
Cite Document
2259 Exhibit: Ex 2259 Avastin Prescribing Information Part 3 of 4
Document
IPR2021-00816, No. 2259-397 Exhibit - Ex 2259 Avastin Prescribing Information Part 3 of 4 (P.T.A.B. Jan. 19, 2022)
|
|
Cite Document
2142 Exhibit: Ex 2142 NOVITCCH01494800 PUBLIC REDACTED VERSION
Document
IPR2021-00816, No. 2142-420 Exhibit - Ex 2142 NOVITCCH01494800 PUBLIC REDACTED VERSION (P.T.A.B. Jan. 19, 2022)
|
|
Cite Document
2276 Exhibit: Ex 2276 Roche Finance Report for 2017 Part 1 of 3
Document
IPR2021-00816, No. 2276-416 Exhibit - Ex 2276 Roche Finance Report for 2017 Part 1 of 3 (P.T.A.B. Jan. 19, 2022)
|
|
Cite Document
2276 Exhibit: Ex 2276 Roche Finance Report for 2017 Part 2 of 3
Document
IPR2021-00816, No. 2276-417 Exhibit - Ex 2276 Roche Finance Report for 2017 Part 2 of 3 (P.T.A.B. Jan. 19, 2022)
|
|
Cite Document
1192 Exhibit: Highlights of Prescribing Information, Susvimo, revised October 2021...
Document
IPR2021-00816, No. 1192-632 Exhibit - Highlights of Prescribing Information, Susvimo, revised October 2021, (P.T.A.B. Apr. 15, 2022)
|
|
Cite Document
1199 Exhibit: Excerpt of Wooldridge, Jeffrey M, Econometric Analysis of Cross Sec...
Document
IPR2021-00816, No. 1199-648 Exhibit - Excerpt of Wooldridge, Jeffrey M, Econometric Analysis of Cross Section and Panel Data, MIT Press (P.T.A.B. Apr. 15, 2022)
|
|
Cite Document
1237 Exhibit: ���Highlights of Prescribing Information,��� Eylea, FDA, revised Octobe...
Document
IPR2021-00816, No. 1237-631 Exhibit - ���Highlights of Prescribing Information,��� Eylea, FDA, revised October 2014 (P.T.A.B. Apr. 15, 2022)
|
|
Cite Document
1100 Exhibit: Declaration of James Agalloco
Document
IPR2021-00816, No. 1100-496 Exhibit - Declaration of James Agalloco (P.T.A.B. Apr. 15, 2022)
|
|
Cite Document
1243 Exhibit: Kevin L Varghese, No Need to Neglect Nexus Prosecution Lessons fr...
Document
IPR2021-00816, No. 1243-642 Exhibit - Kevin L Varghese, No Need to Neglect Nexus Prosecution Lessons from FOX Factory v SRAM, Intellectual Property Tech Law J, 326 16 June 2020 (P.T.A...
|
|
Cite Document
